Patent 11298401 was granted and assigned to Amicrobe on April, 2022 by the United States Patent and Trademark Office.
Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.